C07K 14/70571
For neuromediators
Official title: {for neuromediators, e.g. serotonin receptor, dopamine receptor}
C07K14/70571 (For neuromediators) appears on 645 US grants and 722 published applications in this corpus.
Search patents in C07K- Granted patents
- 645
- Published applications
- 722
- Assignees
- 419
- Inventors
- 1,598
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 7 | 0 |
| 1995 | 13 | 0 |
| 1996 | 21 | 0 |
| 1997 | 32 | 0 |
| 1998 | 45 | 0 |
| 1999 | 40 | 0 |
| 2000 | 43 | 0 |
| 2001 | 40 | 10 |
| 2002 | 57 | 70 |
| 2003 | 29 | 90 |
| 2004 | 26 | 36 |
| 2005 | 16 | 60 |
| 2006 | 22 | 41 |
| 2007 | 24 | 27 |
| 2008 | 13 | 19 |
| 2009 | 13 | 27 |
| 2010 | 14 | 16 |
| 2011 | 5 | 20 |
| 2012 | 18 | 22 |
| 2013 | 8 | 18 |
| 2014 | 18 | 13 |
| 2015 | 11 | 17 |
| 2016 | 11 | 14 |
| 2017 | 10 | 18 |
| 2018 | 6 | 19 |
| 2019 | 15 | 25 |
| 2020 | 12 | 26 |
| 2021 | 14 | 24 |
| 2022 | 18 | 27 |
| 2023 | 11 | 20 |
| 2024 | 9 | 31 |
| 2025 | 7 | 19 |
| 2026 | 6 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutic use of P75NTR neurotrophin binding protein14 Jul 2026US 12,679,880 B2Levicept LTD
- Chimeric autoantibody receptor (CAAR) that binds autoantibodies targeting the central nervous system in neurological autoimmune disease5 May 2026US 12,617,835 B2Deutsches Zentrum Fur Neurodegenerative Erkrankungen E.V. (Dzne)
- Conus-based toxin peptides, nucleic acids encoding same and uses thereof in modulating NMDA receptors24 Mar 2026US 12,583,892 B2Technion Research & Development Foundation Limited
- Methods for cell-type specific profiling to identify drug targets17 Mar 2026US 12,577,609 B2The Rockefeller University
- Modified ligand-gated ion channels and methods of use10 Mar 2026US 12,570,705 B2Howard Hughes Medical Institute
- Modified ligand-gated ion channels and methods of use24 Sep 2026US 2026/0285926 A1Howard Hughes Medical Institute
- Modulating the properties of gpcr-based sensors via c-terminus isoforms30 Jul 2026US 2026/0217790 A1Georgia Tech Research Corporation
- Combination for treatment of autoimmune diseases23 Jul 2026US 2026/0207722 A1Bonsai Biotherapeutics AB
- Peptides capable of inhibiting protein-protein interactions at gabab1a subunit and uses thereof9 Jul 2026US 2026/0193293 A1UniversitäT Basel
- Ratiometric fluorescent sensor constructed based on g protein-coupled receptor and its construction method9 Jul 2026US 2026/0193314 A1Peking University
Most cited
By later US patents
- Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof110US 6,140,509 AArena Pharmaceuticals, Inc. · 2000
- 5-HT2A receptor inverse agonists105US 6,107,324 AArena Pharmaceuticals, Inc. · 2000
- Methods for screening for binding partners of G-protein coupled receptors103US 9,260,505 B2Heptares Therapeutics Limited · 2016
- DNA encoding serotonin 1C (5HT1c) receptor, isolated 5HT1c receptor, mammalian cells expressing same and uses thereof102US 4,985,352 AThe Trustees of Columbia University in the City of New York · 1991
- High purity albumin and method of producing99US 5,728,553 ADelta Biotechnology Limited · 1998